FDA Issues Draft Guidance on Tackling Misinformation About Approved Products

To aid drug and device makers in battling misinformation about their products, the FDA has issued a 21-page question-and-answer draft guidance that provides firms with ways to address the issue.
Source: Drug Industry Daily